Stephen Squinto

Investing Profile

Sweet spot: $4M Range: $1M–$75M Fund: $18B

About Stephen Squinto

We are an investment firm dedicated exclusively to the healthcare sector.

OrbiMed thesis

Many technologies with the potential to cure disease are advancing rapidly. How long can healthy humans live, 120 years? 150 years? Our portfolio companies are working hard to find out. Filter by Sector Biopharmaceutical Diagnostics/Tools Healthcare IT Healthcare Services Medical Device Filter by Region Asia Europe / MENA North America Sort Alphabetical Newest Oldest Clear All Filters Clear All Filters Filter by Sector Biopharmaceutical Diagnostics/Tools Healthcare IT Healthcare Services Medical Device Filter by Region Asia Europe / MENA North America Sort Alphabetical Newest Oldest Apply Load

Sector and stage focus

  • Seed: Pharmaceuticals, BioTech
  • Series A: BioTech, Pharmaceuticals
  • general: New York City

Is Stephen Squinto a fit for your round?

Upload your pitch deck and see whether Stephen Squinto appears in your top 20 matches.

Find investors for your deck